| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/13/2002 | CN1335881A UME extract having medicinal effects and compositions containing the same |
| 02/13/2002 | CN1335850A Quinoline derivatives |
| 02/13/2002 | CN1335849A Pyrrolopyrimidines as protein kinase inhibitors |
| 02/13/2002 | CN1335846A Pyrano, piperidino and thiopyrano compounds and methods of use |
| 02/13/2002 | CN1335845A 3,4-dihydro-2H-benzo[1,4] oxazinyl-methyl [3-(1H-indol-3-yl)-alkyl]-amines |
| 02/13/2002 | CN1335844A New 1,4-disubstituted cyclohexane derivatives for the treatment of depression |
| 02/13/2002 | CN1335843A Thiourea inhibitors of herpes viruses |
| 02/13/2002 | CN1335842A Process to prepare cyclic-sulfur fluorine containing oxazolidinones |
| 02/13/2002 | CN1335841A N-(iminomethyl) amine derivatives, their preparation, their use as medicines and compositions containing them |
| 02/13/2002 | CN1335839A Bis-sulfonamides |
| 02/13/2002 | CN1335838A Pyrimidine compounds |
| 02/13/2002 | CN1335837A Imidazole compounds and medicinal use thereof |
| 02/13/2002 | CN1335836A Tricyclic pyrazole derivatives |
| 02/13/2002 | CN1335835A Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5HT1A receptor activity |
| 02/13/2002 | CN1335834A Aromatic heterocycle compounds having HIV integrase inhibiting activities |
| 02/13/2002 | CN1335787A Apparatus and process for preparing crystalline particles |
| 02/13/2002 | CN1335778A Inhibitors against vascular lipid deposition containing chymase-inhibiting substances |
| 02/13/2002 | CN1335777A Preventives or remedies for myocarditis, dilated cardiomyopathy and cardiac insufficiency containing NF-K B inhibitors as the active ingredient |
| 02/13/2002 | CN1335775A Bioflavonoids, anthocyanins and phenolic compounds from cherries for inhibiting inflammation and cyclooxygenase enzymes |
| 02/13/2002 | CN1335774A Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition |
| 02/13/2002 | CN1335773A Method of using (2-imidazolin-2-ylamino) quinoxalines in treating neural injury |
| 02/13/2002 | CN1335772A Use of apomorphine in the manufacture of a medicament for the treatment of organic erectile dysfunction in males |
| 02/13/2002 | CN1335771A N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 02/13/2002 | CN1335770A Spisulosine compounds having antitumour activity |
| 02/13/2002 | CN1335769A Controlled release formulation of divalproex sodium |
| 02/13/2002 | CN1335768A Multiparticulate modified release composition |
| 02/13/2002 | CN1335767A Sustained release matrix systems for highly soluble drugs |
| 02/13/2002 | CN1335766A A process for the preparation of suspensions of drug particles for inhalation delivery |
| 02/13/2002 | CN1335764A Substrate composition and method of use for sequestration of skin irritants |
| 02/13/2002 | CN1335763A Skin care compositions containing cis-9, trans-11 linoleic acid |
| 02/13/2002 | CN1335757A Hemostatic polymer useful for rapid blood coagulation and hemostasis |
| 02/13/2002 | CN1335749A Method and compositions for treatment of cell proliferative disorders |
| 02/13/2002 | CN1335317A Process for producing pyrazolo [4,3-d] pyrimidine-7-ketonic compound and its intermediate |
| 02/13/2002 | CN1335316A New N-triazolyl methyl piperazine derivate using as neurokinin receptor antagonistic agent |
| 02/13/2002 | CN1335309A New eka-favone and its application in preparation of cosmetic and dermatology |
| 02/13/2002 | CN1335304A Novel carbamic acid ester compound containing amino thionic group and its producing process |
| 02/13/2002 | CN1335301A 3-cyano-2,4,5-trifluoro-benzoic acid and its derivant and their application |
| 02/13/2002 | CN1335293A Extraction process of effective rhubarb component, fast released Sanhuang prepn and its prepn process |
| 02/13/2002 | CN1335171A Gynopathy treating Chinese medicine with functions of diminishing inflammation and eliminating spot and its prepn |
| 02/13/2002 | CN1335164A Leukoderma treating medicine and its prepn |
| 02/13/2002 | CN1335160A Burns treating ointment with functions of removing necrosis and promoting granulation |
| 02/13/2002 | CN1335143A Chinese medicine for treating mastoproliferation |
| 02/13/2002 | CN1335138A Composition containing pearl powder and ascorbic acid |
| 02/13/2002 | CN1335137A Soluble nutritious powder with elements, vitamins and amino acids and its prepn |
| 02/13/2002 | CN1335135A Artificial skin powder prepn containing sodium hyaluronate and its prepn |
| 02/13/2002 | CN1335134A Composition and method for preventing and treating breast cancer |
| 02/13/2002 | CN1335133A Composition and method for preventing and curing breast cancer |
| 02/13/2002 | CN1335132A Application of ornidazole in wide-spectrum antifungal medicine |
| 02/13/2002 | CN1335131A Local administration preparation |
| 02/13/2002 | CN1335130A Otopathy treating medicine |
| 02/13/2002 | CN1335129A Gynopathy treating medicine |
| 02/13/2002 | CN1335128A Onychomycosis treating medicine |
| 02/13/2002 | CN1335127A Probucol clathrate capsule and its prepn process |
| 02/13/2002 | CN1079097C Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives |
| 02/13/2002 | CN1079096C Arylsulfonylimidazolone derivatives as antitumor agent |
| 02/12/2002 | US6346633 Anti-tumuor agents |
| 02/12/2002 | US6346626 Drugs for treatment of skin disorders such as acne, seborrhea, androgenic alopecia and hirsutism, or in the topical treatment of squamous cell carcinoma |
| 02/12/2002 | US6346624 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/12/2002 | US6346622 Enantiomorphs and isomers |
| 02/12/2002 | US6346620 Methods for preparation of 2-(4-(4-(4,5-dichloro-2-methylimidazol-1-yl)butyl)-1-piperazinyl)-5-fluoropyrimidine and salts thereof |
| 02/12/2002 | US6346608 MecB |
| 02/12/2002 | US6346551 Antibacterial, antifungal, antiviral, bactericidal and/or sterilization agents, anticancer drugs, blood coagulation and fibrinolysis inhibitors and/or blocking agents, inhibitory and/or blocking agents of antigen-antibody reactions |
| 02/12/2002 | US6346550 Hydroxylation activated prodrugs |
| 02/12/2002 | US6346549 Treating symptoms of drug withdrawal, treating to aid in cessation of, or preventing relapse after cessation of, drug misuse, compulsive gambling, compulsive shopping or compulsive sexual behaviour |
| 02/12/2002 | US6346548 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| 02/12/2002 | US6346547 N-substituted amino acids, antioxidant pharmaceutical compositions containing n-substituted amino acids and methods for preventing cardiovascular diseases and/or preventing and/or treating antioxidant responsive diseases therewith |
| 02/12/2002 | US6346546 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them |
| 02/12/2002 | US6346544 By scavenging reactive nitrogen species, less arterial blockage in thrombosis |
| 02/12/2002 | US6346543 Administering baccatin derivative as anticarcinogenic agent |
| 02/12/2002 | US6346542 Applying racemic mixture; controlling fleas and ticks; veterinary medicine |
| 02/12/2002 | US6346541 Antitumor and anticarcinogenic agents for breast, lung, and skin cancer |
| 02/12/2002 | US6346540 1-(1,2-disubstituted pipeidinyl)-4-substituted piperidine derivatives |
| 02/12/2002 | US6346539 Treatment of skin conditions |
| 02/12/2002 | US6346537 Medicinal composition |
| 02/12/2002 | US6346536 Benzopyranoisoquinolone derivatives; neurodegenerative and brain disorders; reperfusion injuries; antiischemic agents |
| 02/12/2002 | US6346533 Dissolving in solvent; low to high speed drying; high air pressure atomizing; reduced particle size; bioavailability |
| 02/12/2002 | US6346532 Antidiabetic, antilipemic, and hypoglycemic agents; adrenergic stimulants |
| 02/12/2002 | US6346531 G-CSF mimetics |
| 02/12/2002 | US6346530 Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil |
| 02/12/2002 | US6346529 Antiviral therapy using thiazine dyes |
| 02/12/2002 | US6346528 Side effect reduction compared to olanzapine; capsules or tablets; psychological, gastrointestinal and bipolar disorders; anxiolytic agents, antidepressants |
| 02/12/2002 | US6346527 Guanidine derivatives |
| 02/12/2002 | US6346526 Carbapenicillin with 1,1-dioxo-2,3-dihydronaphtho(1,8-de)(1,2)thiazin-2-yl-substituent; treating staphylococcus infections resistant to methicillin; side effect reduction |
| 02/12/2002 | US6346525 Carbapenicillin with 1,1-dioxo-2h-1-thia-2,3-diaza-naphthalene substituent; treating staphylococcus infections resistant to methicillin; side effect reduction |
| 02/12/2002 | US6346524 Cyclical dosing with rest periods |
| 02/12/2002 | US6346523 Controlling temperature and pressure of solution of budesonide in solvent and supercritical fluid so that dispersion and extraction occur concurrently; crystalline, fineness; respiratory system disorders |
| 02/12/2002 | US6346521 Osteogenesis promoters for bone disorders |
| 02/12/2002 | US6346520 Antitumor and anticarcinogenic agents; psoriasis |
| 02/12/2002 | US6346518 Administering as a complex with cyclodextrin to treat fungal infections |
| 02/12/2002 | US6346517 Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders |
| 02/12/2002 | US6346516 Drug delivery of (quaternary) amine salt and macromolecule; gene therapy |
| 02/12/2002 | US6346422 Method of selecting bacterial strains |
| 02/12/2002 | US6346409 Tryptophenyl tRNA synthetase from Streptococcus pneumoniae |
| 02/12/2002 | US6346398 Ribozyme or antisense nucleic acid which inhibits synthesis, gene expression and/or stability of messenger rna encoding the flt-1 receptor of human or mouse receptor; treatment of diabetic retinopathy; angiogenesis inhibitors |
| 02/12/2002 | US6346391 Treating infection by administering drug to which the microorganism is resistant and an inhibitor of an acrab-like efflux pump |
| 02/12/2002 | US6346283 Nervous system disorders |
| 02/12/2002 | US6346282 Synergistic compositions for treating nervous system disorders |
| 02/12/2002 | US6346280 Composition and methods for inhibiting the formation of brain amyloid deposits |
| 02/12/2002 | US6346278 Lipid extract of perna or mytilus |
| 02/12/2002 | US6346275 Drugs for immunology residues of corallinaceae, seaweed derivatives |